Remote Vinyasa Yoga Program for Heart Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorWest Virginia University
About this trial
The purpose of this study is to test a 12-week vinyasa yoga (flow yoga) intervention via Zoom. This program will be for 30 individuals with high blood pressure. 15 will receive the intervention and 15 will follow their usual routine. The investigators will determine if this vinyasa yoga program is feasible and acceptable in this population. Investigators will measure and compare blood pressure and other health responses such as physical health and well-being before and after participants complete the intervention or usual care period. The investigators hope to demonstrate that vinyasa yoga is a good option to improve heart health in people with high blood pressure.
Primary Objective - Examine the feasibility, acceptability, and preliminary efficacy of a 12-wk remotely-delivered vinyasa yoga intervention (3 x per week) on cardiovascular (CV) health in adults with hypertension (HTN).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals with a resting systolic BP >130 mmHg
Disqualifiers
Report currently meeting aerobic activity guidelines (150 min/wk)
Practice yoga regularly (1 or more day/wk in the past month)
Have physical limitations or a major medical condition contraindicating yoga or assessments
Have uncontrolled HTN (systolic BP 160 mmHg or diastolic BP 100 mmHg)
Trial design
Design model
Parallel
Treatments tested in this trial
Vinyasa Yoga
BehavioralEach yoga session will begin with 2 minutes of integration poses (Child's Pose, Downward Facing Dog, Ragdoll, and Mountain Pose), followed by \~20 minutes of Sun Salutations A and B (up to 5 of each). The Standing Series, lasting \~25 minutes, will include various standing and balancing poses from the Journey into Power sequence. Seated and supine stretches (including seated stretches, a yoga inversion, a reclined twist) will last \~8 minutes, and the session will conclude with 5 minutes of Savasana for final relaxation.
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Vinyasa YogaExperimental treatment 1 intervention
Group B: Standard RoutineNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in Carotid-Femoral Pulse Wave Velocity
Change from baseline to 12 weeks. Measure of central arterial stiffness (meters/second) measured by oscilometiric pulse wave velocity. A value of 10 m/s and above is classified as an unfavorable value.
Time frame
Baseline to 12 weeksSecondary outcomes
1
Change in systolic blood pressure
Change from baseline to 12 weeks. Measure of pressure in the arteries when the heart beats (millimeters of mercury) measured by an automated blood pressure device with an oscillometric cuff. A value of less than 120 mmHg is considered normal, elevated is a value 120-129 mmHg, and high blood pressure is any value 130 or above.
Time frame
Baseline to 12 weeks2
Change in diastolic blood pressure
Change from baseline to 12 weeks. Measure of pressure in the arteries between heart beats (millimeters of mercury) measured by an automated blood pressure device with an oscillometric cuff. A value of less than 80 mmHg is considered normal, and high blood pressure is any value 80 or above.
Time frame
Baseline to 12 weeks3
Change in augmentation pressure
Change from baseline to 12 weeks. Difference in pressure (millimeters of mercury) measured by oscilometiric pulse wave analysis. A value between 20 and 80 mmHg is considered within the normal range, while values at or above 80 mmHg are regarded as unfavorable and may indicate increased cardiovascular risk.
Time frame
Baseline to 12 weeks4
Change in augmentation index
Change from baseline to 12 weeks. Measure of systemic arterial stiffness (%), measured by oscillometric pulse wave analysis. A value under 33% is considered normal while a value above 33% is considered unfavorable.
Time frame
Baseline to 12 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov